You are on page 1of 1

Waist and hip circumferences in different populations

A Molarius et al
124
22 Dobson AJ, Kuulasmaa K, Moltchanov V, Evans A, Fortman S, 29 Laws A, Terry RB, Barret-Connor E. Behavioral covariates of
Jamrozik K, Sans S, Tuomilehto J for the WHO MONICA waist-to-hip ratio in Rancho Bernardo. Am J Public Health
Project. Changes in cigarette smoking among adults in 35 1990; 80: 1358 ± 1362.
populations during the 1980s. Tobacco Control 1998; 7: 14 ± 21. 30 Bouchard C, Perusse L, Tremblay A, Theriault G. Inheritance
23 Rothman KJ. Modern epidemiology. Little, Brown and Co.: of the amount and distribution of human body fat. Int J Obes
Boston, 1986. 1988; 12 : 205 ± 215.
24 Waterhouse J, Muir CS, Correa P, Powell J (eds). Cancer 31 Selby JV, Newman B, Quesenberry CP, Fabsitz RR, Carmelli
incidence in ®ve continents. IARC: Lyon, 1976, 456. D, Meaney FJ, Slemenda C. Genetic and behavioral in¯uences
25 SAS Institute Inc. SAS=STAT user's guide, Version 6 (4th on body fat distribution. Int J Obes 1990; 14: 593 ± 602.
edn). SAS Institute Inc: Gary, North Carolina, 1989. 32 Ashwell M, Cole TJ, Dixon AK. Ratio of waist circumference
26 Seidell JC, Cigolini M, Charzewska J, Ellsinger BM, Contaldo to height is strong predictor of intra-abdominal fat. BMJ 1996;
F. Regional obesity and serum lipids in European women born 313: 559 ± 560.
in 1948. Acta Med Scand 1988; 723 (Suppl): S189 ± S197. 33 Hsieh SD, Yoshinaga H. Abdominal fat distribution and
27 Ferrario M, Carpenter MA, Chambless LE. Reliability of body coronary heart disease risk factors in men ± waist=height
fat distribution measurements. The ARIC Study Baseline ratio as a simple and useful predictor. Int J Obes 1995; 19:
Cohort results. Int J Obes 1995; 19: 449 ± 457. 585 ± 589.
28 Shimokata H, Muller DC, Andres R. Studies in the distribution 34 Han TS, Lean ME, Seidell JC. Waist circumference remains a
of body fat: effects of cigarette smoking. JAMA 1989; 261: useful predictor of coronary heart disease. BMJ 1996; 312:
1169 ± 1173. 1227 ± 1228.

Appendix 1 Sites and key personnel of contributing MONItoring trends and determinants in CArdiovascular disease (MONICA)
centres

Australia
University of Western Australia, Nedlands: MST Hobbsa, K Jamrozik, R Parsons, CA Spencer.
University of Newcastle, Newcastle: A Dobsona, H Alexander, R Heller.
China
Beijing Heart, Lung and Blood Vessel Research Institute, Beijing: Wu Zhaosua, Wu Ying-Kaib, Risk Factor Survey: Yao Chonghua,
Zhang Ruisong.
Czech Republic
Institute for Clinical and Experimental Medicine, Prague: Z SkodovaÂa, Z Pisa, J CerovskaÂ, J PikhartovaÂ, P Vojtisek, L Berka, Z Cicha, M
Hoke.
Denmark
Centre of Preventive Medicine (The Glostrup Population Studies), Copenhagen University: M Schrolla, M Kirchhoff, A Sjùl, KK
Thomsen.
Finland
National Public Health Institute, Helsinki: J Tuomilehtoa, P Puskab, C-G Gref, H Korhonen, M Jauhiainen.
France
National Institute of Health and Medical Research (U258), Paris: J Richardc, A Bingham.
National Institute of Health and Medical Research (INSERM 326), Toulouse: JP Camboua, J Ferrieresa, J-B Ruidavets, P Marques-
Vidal.
Germany
GSF-Institute of Epidemiology, Neuherberg=Munich: U Keila, A DoÈring, B Filipak, HW Hense.
Centre for Epidemiology & Health Research, Berlin (from October 1990. Previously German Democratic Republic): W Bartha, L
Heinemanna, A Assmann, E Classen.
Italy
Institute of Cardiology, Regional Hospital, Udine: D Vanuzzoa, L Pilotto, G Cignacco, G Zanata, M Scarpa, R Marini, M Spanghero, G
Zilio.
University of Milan, Institute of Occupational Health, Milan: GC Cesanaa, M Ferrarioa, R Sega, P Mocarelli, G DeVito, F Valagussa.
Spain
Institute of Health Studies, Department of Health and Social Security, Barcelona: S Sansa, I Balaguer-Vintroa, LI BalanaÁ, G Paluzie, T
Puig.
Sweden
Department of Medicine, Ostra Hospital, GoÈteborg: L Wilhelmsena, A Rosengren, A Dotevall.
UmeaÊ University Hospital, LuleaÊ-Boden Hospital and Kalix Hospital, Departments of Medicine: K Asplunda, F Huhtasaaria, V
Lundberg, M Peltonen, B Stegmayr.
United Kingdom
University of Dundee, Dundee, Scotland: H Tunstall-Pedoea, WCS Smithd, R Tavendale, K Barrett, C Brown, M Shewry.
Yugoslavia
Health Centre `Novi Sad', Novi Sad: M Planojevica, D Jakovljevicb, A Svircevic, M Mirilov, T Strasser.
MONICA Management Centre ± Geneva, World Health Organization, Geneva: I Martine, I Gyarfasf, Z Pisaf, SRA Doduf, S BoÈthigf, MJ
Watson, M Hill.
MONICA Data Centre ± Helsinki, National Public Health Institute, Helsinki, Finland: K Kuulasmaae, J Tuomilehtof, V Moltchanov, A
Molarius, E Ruokokoski.
MONICA Steering Committee: M Hobbs (Chair), M Ferrario (Publications Coordinator), H Tunstall-Pedoe (Rapporteur), K Asplund, A
Evans, K Kuulasmaa, A Shatchkute (WHO, Copenhagen). Consultant: A Dobson.
Previous Steering Committee Members: S Sans, F Gutzwiller, SP Fortmann, A Menotti, P Puska, SL Rywik, U Keil, R Beaglehole,
former chiefs of Cardiovascular Disease Unit Headquarters (CVD=HQ), Geneva, V Zaitsev, J Tuomilehto. Former Consultants: MJ
Karvonen, RJ Prineas, M Feinleib, FH Epstein, Z Pisa, OD Williams.
a
Principal Investigator; b Former Principal Investigator; c
Country Coordinator; d
Co-Principal Investigator; e
Responsible Of®cer;
f
Former Responsible Of®cer

You might also like